Ambu, DK0060946788

Ambu stock heads into the open after a near 3% UBS-driven drop

Published on 09/18/2026 at 05:47 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

At the close on September 16, 2026, Ambu stock ended the Nasdaq Copenhagen session down close to 3% in Danish kroner terms, lagging the broader Danish market. Ambu stock remains under pressure as investors digest UBS’s rating change and price target cut.

SchwarzweiĂź-Reportage aus dem Operationssaal mit Endoskopie-Technik
Ambu A/S (DK0060946788) dokumentiert schwarzweiĂź eine dramatische Operationssaal-Szene mit Endoskopie-AusrĂĽstung im Krankenhaus, Illustration mit AI erstellt.

Ambu stock closed lower on Nasdaq Copenhagen on September 16, 2026, ending the session down close to 3% in Danish kroner compared with the prior close. Per exchange data, the shares finished the day near the lower end of a relatively narrow intraday range, while the broader Danish equity market declined less over the same session.

September 16, 2026 in numbers

Ambu A/S (ISIN DK0060946788) saw continued selling pressure on September 16, 2026, with the stock slipping nearly 3% on Nasdaq Copenhagen as investors reacted to a recent analyst downgrade and price target cut from UBS earlier in the week. As Ad-Hoc-News reported on September 16, 2026, UBS shifted its recommendation on Ambu to neutral from buy and cut its 12 month price target, a change that weighed on the shares and contributed to the session decline. The stock traded in a modest intraday band that day, with the closing price closer to the low than the high, and turnover stayed broadly in line with recent averages, indicating steady selling rather than a sharp spike in activity.

According to a follow up piece from Ad-Hoc-News, the near 3% loss left Ambu underperforming its Copenhagen reference index on September 16, 2026, as the broader market fell less than the stock. That move extended Ambu’s recent underperformance against Danish blue chip peers and kept the shares below the level implied by the revised UBS target, underscoring the cautious tone around the name after the downgrade.

UBS downgrade shapes today’s focus

Today, September 18, 2026, Ambu enters the new Nasdaq Copenhagen session with the UBS rating change and target cut still setting the tone for sentiment. As Ad-Hoc-News highlighted, the revised UBS stance signals a more reserved view on Ambu’s medium term prospects, so any further analyst commentary or company communication today could influence how the stock trades into the open. In the wider backdrop, moves in Danish and European health care names and the local benchmark index may also play a role for Ambu today, particularly if new macro or sector headlines emerge that affect medical equipment demand or reimbursement expectations.

Disclaimer...

en | DK0060946788 | AMBU | boerse | 70121749 | bgmi